This marks the hospital’s 24th transplant using stem cells from a sibling donor over the past 2 years, further demonstrating its medical expertise in treating hereditary hematological disorders.
 |
| Doctors from Hue Central Hospital present flowers to congratulate the patient’s family on the day of discharge |
B.H.N.Y. was diagnosed with Beta-thalassemia at just 9 months old. For years, the child had to undergo regular blood transfusions every 3 to 4 weeks to maintain her health. Human leukocyte antigen (HLA) testing showed a full 12/12 match with her 11-year-old biological brother, paving the way for an allogeneic hematopoietic stem cell transplant.
After conducting comprehensive examinations and in-depth assessments, followed by a hospital-wide consultation, the hospital’s Board of Directors agreed on a treatment approach to develop a transplant plan tailored to the patient’s health condition. Thanks to close coordination among medical specialties throughout the treatment, care, and management of complications, the patient’s blood cell counts have recovered, her health has gradually stabilized, and she has met all discharge criteria. The successful transplant offers the child the prospect of no longer relying on regular blood transfusions, paving the way for a healthier life and more normal development.
Hue Central Hospital began developing its pediatric hematopoietic stem cell transplantation program in 2019. In September 2024, the hospital officially introduced hematopoietic stem cell transplantation for the treatment of Thalassemia, becoming the first medical facility in the Central and Central Highlands regions and the second nationwide to perform this technique.
To date, the hospital has performed 84 pediatric stem cell transplants, including 24 allogeneic transplants for Thalassemia using stem cells donated by biological siblings.
The hospital’s ongoing efforts to master and advance specialized hematopoietic stem cell transplantation techniques not only strengthen its position in pediatric hematology but also create greater opportunities for effective treatment for children with hereditary blood disorders across Vietnam.